Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2024
Related insights
More from our insights
San Francisco Bay Area biotech advances Phase I-II cancer immunotherapy trial with Fortrea
A San Francisco Bay Area biotech company approached Fortrea to manage a Phase I-II clinical trial evaluating a personalized, neoantigen-based vaccine.
ケーススタディをダウンロード
Future directions in liquid biopsy technology
Recent technological advancements have dramatically improved the sensitivity of liquid biopsies, enabling earlier diagnosis, precise treatment selection and enhanced disease monitoring.
詳細はこちらから
Guiding a biotech’s development of an immunotherapy cancer treatment with 'out-of-the-box' thinking
This case study delves into how Fortrea helped guide a sponsor's immunotherapy cancer treatment with out-of-the-box thinking.
ケーススタディをダウンロード
Aligning core values to for a tripartite partnership and advance an oncology program
A partnership model matched the sponsor’s needs and enabled transparency in each interaction.
ケーススタディをダウンロード
Our latest oncology publications
Our collaborative approach can result in co-authorship of peer-reviewed journal articles based on projects we’ve supported.
資料をダウンロード
Clinical Development in the Precision Medicine Era
The era of precision medicine is reshaping oncology trials, offering unprecedented opportunities to tailor treatments to individual genetic profiles. This transformation brings challenges in trial design and execution, and companies must adapt their clinical development strategies to stay ahead.
詳細はこちらから
It is never too early to start a strategic plan for oncology product development in the APAC region
In oncology, a goal-oriented, holistic strategic plan is crucial, even in the earliest phases of product development.
詳細はこちらから
A Scientific Journey in the Midst of the Russia/Ukraine Conflict
Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict.
詳細はこちらから